Opportunities for traditional Chinese medicine to address unmet challenges in modern healthcare  by Cheng, Yung-Chi
ble at ScienceDirect
Journal of Traditional and Complementary Medicine 5 (2015) 2e4Contents lists availaHOSTED BY
Journal of Traditional and Complementary Medicine
journal homepage: http : / /www.elsevier .com/locate/ j tcmePerspectivesOpportunities for traditional Chinese medicine to address unmet
challenges in modern healthcare
Yung-Chi Cheng a, b, *
a Yale University School of Medicine, Yale University, New Haven, CT, USA
b Consortium for the Globalization of Chinese Medicine (CGCM), Yale University, New Haven, CT, USAa r t i c l e i n f oArticle history:
Available online 7 January 20151. Evolving the scope of medicine to reﬂect today's changing
environment
Owing to advances in medical science and the increased effec-
tiveness of public health education, life spans are increasing and
leading to a new set of major public health challenges around age-
associated diseases, including cancer, cardiovascular disease, bone
function degeneration, neuronal degeneration, immune dysfunc-
tion, and metabolic disease.
The needs of an aging and growing global population require an
evolution in drug developmentdone more focused on prevention
than medical approaches of the past. Governments are refocusing
healthcare policies from disease treatment to disease prevention,
and, in turn, the pharmaceutical industry is shifting more resources
from the development of medicines for treatment toward discov-
ering new methods of prevention. Although their development
may be slow, vaccines are an example of effective preventative
medicinedwidely used and demonstrating long-term healthcare
cost savings.
Improving the efﬁcacy of medicine is also an important issue.
Adjuvant medicine is recognized for its ability to improve the ef-
ﬁcacy of other medicines, by working synergistically to decrease
side effects and enhance bioavailability. Borneo and Panax pseudo-
ginseng is an example of a formulationwhose design is important to
its effectiveness and bioavailability. In view of these trends and
challenges, the scope of medicine needs to adapt, and this should
require a more holistic approach.* Corresponding author. Department of Pharmacology, Yale University School of
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discovery
A reductive approach focusing on treatment is not sufﬁcient to
meet the challenges facing modern medicine. Because diseases can
be caused by a variety of factors, it is difﬁcult to isolate single
chemical compounds with deﬁned targets for the treatment and
prevention of diseases. Additionally, when a treatment results in
multiple side effects, it is also challenging to ﬁnd a single drug that
can comprehensively address a variety of side effects. Because of
the heterogeneous manifestation of disease, a host of factors need
to be taken into consideration in developing treatments. Different
patients with the same disease can have different responses to a
given treatment. Owing to the variety of possible genetic mutations
and epigenetic alterations of tumor cells, cancer treatment with
target-oriented drugs alone has both value and limitations. Because
many drugs for cancer and chronic disease treatment and preven-
tion require long-term use, toxicity may aggregate over time.
Development of drug resistance and compensatory mechanisms is
often an issue upon treatment. To overcome these different chal-
lenges, a polychemical approach can be explored.3. A new paradigm for future medicine
Polychemical medicine utilizes a systems biological approach to
target multiple mechanisms of disease treatment and prevention,
rather than focusing on treatment with single chemical medicines.
There are two major approaches to polychemical medicine: (1) a
“step-by-step” approach that evaluates the efﬁcacy of combination
treatment through trial and error; and (2) a “learning from history”
approach that reexamines historical medical practices as the basis
for reinventing modern medicine.
Traditional Chinese medicine (TCM) has been an effective pol-
ychemical medical approach for centuries. TCM includes multiple
approaches for the treatment of complex disease and methods for
disease prevention, as well as improving quality of life. TCM could
be considered a model for other future polychemical medical
approaches.
The chemical and botanical compounds used in TCM have the
ﬂexibility to function in a variety of ways in order to addressrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. PhytomicsQC integrates technologies for chemical marker compound analysis and chemical ﬁngerprints, comprehensive bioresponse ﬁngerprints, and in vivo animal
pharmacology validation.2
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callydto treat speciﬁc diseases or symptoms, as well as a complex
network of related issues. TCM is prescribed as “individualized
medicine” to optimize its usage. These aspects make TCM a suitable
approach to meet the complex challenges facing modern medicine.
Basic regulatory requirements for modern drugs should focus
on: (1) consistency of preparation; (2) evidence-based clinical ef-
ﬁcacy; (3) safety; and (4) certain knowledge of its action. To make
preparations of herbal medicinewith consistency, authentication of
sources for herbal and botanical compounds is a critical issue, and
accurate identiﬁcation is essential in order to prevent misuse. In
order to ensure a high degree of consistency, High Quality Herb
Agricultural Practices (HQHAP) is currently considered a good
agricultural practice. HQHAP is an advanced approach to stan-
dardizing herbal and botanical agricultural practices. Beyond
morphological, microscopic, and gene sequence analysis, HQHAP
emphasizes the chemical analysis of herbs in vitro (solution state)
and in situ (solid state), including matrix-assisted laser desorption/
ionization mass spectrometry to determine a chemical image of
herbal tissue.14. A two-tiered approach to botanical quality control
The challenges of complex diseases should be addressed holis-
tically through a systems biological approach, which includes
science-based quality control regulations for the complex botanical
compounds. Comprehensive regulatory oversight and quality con-
trol measures are required. A two-tiered approach is useful for
ensuring botanical quality control. Tier one includes an analysis of
the chemical and bioresponse ﬁngerprints, and informatics/data
mining technologies. Tier one's aim focuses on a global and relative
quantitation. Tier two includes a simpliﬁed chemical and biological
analysis of pharmacological activity, including the impact on tar-
geted enzymes/receptors and genomic pathways. Tier two focuses
on speciﬁc and absolute quantitation. An example of this two-
tiered approach is PhytomicsQCda platform used to conﬁrm the
consistency of PHY906, an herbal medicine used in cancer therapy
in phase III clinical trials (Fig. 1).2 This comprehensive platformmeets the regulatory and scientiﬁc challenges of botanical quality
control.5. Opportunities and challenges for herbal medicine as
cancer treatment
Cancer's high incidence and mortality makes it a critical public
health challenge. To overcome the unmet challenges, two major
healthcare strategies should be considered for the development of
cancer treatment and prevention practices: (1) developing more
selective anticancer drugs with less toxicity; and (2) decreasing the
toxicity of current cancer treatment modalities, without compro-
mising their anticancer activity. In most cases, reductive, single-
chemical approaches can make incremental improvements. How-
ever, holistic polychemical approaches should be considered as
mechanisms to synergistically treat and prevent cancer and chronic
diseases. Clinical trials of herbal and botanical medicines face
several challenges, including proper dosage determination, feasi-
bility of placebo randomized trials, design of add-on studies, and
consideration and evaluation of individualized responses. To
overcome these challenges, multiple disciplines of science and
technology need to work together to advance herbal medicine,
including agricultural science, microbiology and soil science, pro-
cessing and manufacturing technologies, analytical technology,
biological and medical science, and bioinformatics technology,
including database and datamining. In order to effectivelymeet the
challenges of modern medicine and to advance Chinese and herbal
medicine, there needs to be a close collaboration between
academia, industry, and government.3 Because of human, techno-
logical, and ﬁnancial resource limitations, international collabora-
tion is critical for the advancement of holistic approaches to treat
and prevent cancer and chronic diseases.Conﬂicts of interest
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